This inventor holds 21 USPTO granted patents and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: The Procter Gamble Company, Warner Chilcott Company, LLC, Isis Innovation Limited. Active years: 1991-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cincinnati, OH (US) (1991 - 2013)
- Mason, OH (US) (2005 - 2014)
Company Filing History:
15 out of 17,173 
3 out of 39 
2 out of 330 
Years Active: 1991-2014
Areas of Expertise:
Title: Adam W Mazur: Innovator in Pharmaceutical Compounds
Introduction
Adam W Mazur, a distinguished inventor located in Cincinnati, OH, has made significant contributions to the field of pharmaceuticals, specifically in the development of bisphosphonate compounds. With a portfolio of 21 patents to his name, he is recognized for his innovative approaches in treating bone metabolism disorders.
Latest Patents
Among his latest work, Adam has focused on novel bisphosphonate cyclic acetal compounds. His patents disclose methods of preparing these compounds, along with pharmaceutical compositions that include them. Notably, these compounds are aimed at addressing issues related to abnormal calcium and phosphate metabolism, thus offering potential therapeutic benefits for patients suffering from bone disorders.
Career Highlights
Adam has held key positions in renowned companies, including The Procter & Gamble Company and Warner Chilcott Company, LLC. His experience at these prominent organizations has played a crucial role in shaping his expertise and innovative approach toward pharmaceutical development.
Collaborations
Throughout his career, Adam has collaborated with esteemed colleagues such as Frank Hallock Ebetino and Gary A Piazza. These partnerships have fostered a productive environment for innovation and have contributed to the advancement of research in bisphosphonate compounds.
Conclusion
Adam W Mazur stands out as a prolific inventor with a strong focus on addressing critical health issues through his innovations in bisphosphonate compounds. His impressive patent portfolio and collaborative efforts underscore his commitment to enhancing pharmaceutical treatments and improving patient care in the realm of bone metabolism disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile